OTCQX Video Series: Orexo

Sponsored content

This interview features Nikolaj Sørensen, CEO of Orexo

Orexo is a specialty pharma company with commercial operations in the US and in Sweden developing improved treatments using proprietary drug-delivery technology. This video interview with Nikolaj Sørensen of Orexo covers:

  • The company’s core technology competencies and focus on opioid addiction
  • Orexo’s digital therapy for treatment of opioid addiction and the company’s growth strategy
  • The benefits of trading in the US public markets on OTCQX

This content is provided by OTC Markets and did not involve IR Magazine journalists.

logo-black logo-black
Loading